Risk Factors for De Novo Malignancy Following Lung Transplantation.

@article{Magruder2017RiskFF,
  title={Risk Factors for De Novo Malignancy Following Lung Transplantation.},
  author={Jonathan Trent Magruder and Todd C. Crawford and Joshua C. Grimm and Bo Soo Kim and Ashish S Shah and Errol L. Bush and Robert Samuel DeCosta Higgins and Christian A. Merlo},
  journal={American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons},
  year={2017},
  volume={17 1},
  pages={227-238}
}
Risk factors for non-skin cancer de novo malignancy (DNM) after lung transplantation have yet to be identified. We queried the United Network for Organ Sharing database for all adult lung transplant patients between 1989 and 2012. Standardized incidence ratios (SIRs) were computed by comparing the data to Surveillance, Epidemiology, and End Results Program data after excluding skin squamous/basal cell carcinomas. We identified 18 093 adult lung transplant patients; median follow-up time was… CONTINUE READING